Subtle thinning of retinal layers without overt vascular and inflammatory alterations in a rat model of prediabetes

Mol Vis. 2018 May 18:24:353-366. eCollection 2018.

Abstract

Purpose: Diabetic retinopathy is a neurovascular disease characterized by increased permeability of the blood-retinal barrier, changes in the neural components of the retina, and low-grade chronic inflammation. Diabetic retinopathy is a major complication of diabetes; however, the impact of a prediabetic state on the retina remains to be elucidated. The aim of this study was to assess possible early retinal changes in prediabetic rats, by evaluating changes in the integrity of the blood-retinal barrier, the retinal structure, neural markers, and inflammatory mediators.

Methods: Several parameters were analyzed in the retinas of Wistar rats that drank high sucrose (HSu; 35% sucrose solution during 9 weeks, the prediabetic animal model) and were compared with those of age-matched controls. The permeability of the blood-retinal barrier was assessed with the Evans blue assay, and the content of the tight junction proteins and neural markers with western blotting. Optical coherence tomography was used to evaluate retinal thickness. Cell loss at the ganglion cell layer was assessed with terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL) assay and by evaluating the immunoreactivity of the Brn3a transcription factor. To assess retinal neuroinflammation, the mRNA expression and protein levels of inducible nitric oxide synthase isoform (iNOS), interleukin-1 beta (IL-1β), and tumor necrosis factor (TNF) were evaluated. Iba1 and MHC-II immunoreactivity and translocator protein (TSPO) mRNA levels were assessed to study the microglial number and activation state.

Results: The thickness of the inner retinal layers of the HSu-treated animals decreased. Nevertheless, no apoptotic cells were observed, and no changes in retinal neural markers were detected in the retinas of the HSu-treated animals. No changes were detected in the permeability of the blood-retinal barrier, as well as the tight junction protein content between the HSu-treated rats and the controls. In addition, the inflammatory parameters remained unchanged in the retina despite the tendency for an increase in the number of retinal microglial cells.

Conclusions: In a prediabetic rat model, the retinal structure is affected by the thinning of the inner layers, without overt vascular and inflammatory alterations. The results suggest neuronal dysfunction (thinning of the inner retina) that may precede or anticipate the vascular and inflammatory changes. Subtle structural changes might be viewed as early disturbances in an evolving disease, suggesting that preventive strategies (such as the modification of diet habits) could be applied at this stage, before the progression toward irreversible dysfunction and damage to the retina.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood-Retinal Barrier / drug effects
  • Capillary Permeability / drug effects
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Diabetic Retinopathy / chemically induced
  • Diabetic Retinopathy / diagnosis
  • Diabetic Retinopathy / genetics
  • Diabetic Retinopathy / metabolism
  • Disease Models, Animal
  • Ependymoglial Cells / cytology
  • Ependymoglial Cells / drug effects*
  • Ependymoglial Cells / metabolism
  • Evans Blue / chemistry
  • Gene Expression Regulation
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism
  • Male
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Prediabetic State / chemically induced
  • Prediabetic State / diagnosis*
  • Prediabetic State / genetics
  • Prediabetic State / metabolism
  • Rats
  • Rats, Wistar
  • Receptors, GABA-A / genetics
  • Receptors, GABA-A / metabolism
  • Signal Transduction / drug effects*
  • Sucrose / pharmacology*
  • Tight Junctions / drug effects
  • Tight Junctions / ultrastructure
  • Tomography, Optical Coherence
  • Transcription Factor Brn-3A / genetics
  • Transcription Factor Brn-3A / metabolism
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Carrier Proteins
  • IL1B protein, rat
  • Interleukin-1beta
  • Receptors, GABA-A
  • Transcription Factor Brn-3A
  • Tumor Necrosis Factor-alpha
  • Tspo protein, rat
  • Evans Blue
  • Sucrose
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat